Literature DB >> 22147510

Reasons to consider earlier treatment of chronic HBV infections.

Fabien Zoulim1, William S Mason.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22147510     DOI： 10.1136/gutjnl-2011-300937

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  32 in total

Review 1.  Present and future therapies of hepatitis B: From discovery to cure.

Authors:  T Jake Liang; Timothy M Block; Brian J McMahon; Marc G Ghany; Stephan Urban; Ju-Tao Guo; Stephen Locarnini; Fabien Zoulim; Kyong-Mi Chang; Anna S Lok
Journal:  Hepatology       Date:  2015-10-27       Impact factor: 17.425

Review 2.  Antiviral therapies and prospects for a cure of chronic hepatitis B.

Authors:  Fabien Zoulim; David Durantel
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-01       Impact factor: 6.915

Review 3.  Global strategies are required to cure and eliminate HBV infection.

Authors:  Peter Revill; Barbara Testoni; Stephen Locarnini; Fabien Zoulim
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-24       Impact factor: 46.802

Review 4.  Molecular biology of hepatitis B virus infection.

Authors:  Christoph Seeger; William S Mason
Journal:  Virology       Date:  2015-03-07       Impact factor: 3.616

5.  Reduced Expression of DNA Damage Repair Genes High Mobility Group Box1 and Poly(ADP-ribose) Polymerase1 in Inactive Carriers of Hepatitis B Virus Infection-A Possible Stage of Viral Integration.

Authors:  Rathindra M Mukherjee; Gelli V Shravanti; Aparna Jakkampudi; Ramya Kota; Asha L Jangala; Panyala B Reddy; Padaki N Rao; Rajesh Gupta; Duvvuru N Reddy
Journal:  J Clin Exp Hepatol       Date:  2013-05-22

6.  Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers.

Authors:  Natalia Freitas; Tetyana Lukash; Sumedha Gunewardena; Benjamin Chappell; Betty L Slagle; Severin O Gudima
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

7.  Outcomes of patients with chronic hepatitis B who do not meet criteria for antiviral treatment at presentation.

Authors:  Suna Yapali; Nizar Talaat; Robert J Fontana; Kelly Oberhelman; Anna S Lok
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-17       Impact factor: 11.382

Review 8.  To treat or not to treat the "immunotolerant phase" of hepatitis B infection: A tunnel of controversy.

Authors:  Mohamed A Mekky
Journal:  World J Hepatol       Date:  2014-04-27

Review 9.  The immune tolerant phase of chronic HBV infection: new perspectives on an old concept.

Authors:  Antonio Bertoletti; Patrick T Kennedy
Journal:  Cell Mol Immunol       Date:  2014-09-01       Impact factor: 11.530

Review 10.  Hepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawal.

Authors:  Anais Vallet-Pichard; Stanislas Pol
Journal:  Therap Adv Gastroenterol       Date:  2014-07       Impact factor: 4.409
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.